GRANTIBASE
RegisterSign in
  • Funding
  • Ecosystem
  • Finance
  • More

    • Organizations
    • Projects
    • Insights
    • Pricing
    • Create new initiative
    • Match from website

Grantibase.com — Decision support for funding strategy, discovery, and consortium execution.

© 2026 Grantibase. All rights reserved.·Terms and conditions·Privacy policy·Cookies·Support·Premium features·Pricing

GRANTIBASE

Funded projects

Explore funded EU projects and the organizations behind them — filter by programme, call, country, sector, and more. Results are from completed CORDIS grant records, not open calls; for live funding opportunities, visit Funding.

Filters2Filters2

Filters

Project

Full-text search across title, acronym, topics, keywords, summary, and objective.

Filter by how projects are classified in the dataset.

Matches the EuroSciVoc taxonomy linked to projects, not free-text project topics.

Canonical business sectors mapped from multilingual project signals.

Based on each project's start date.

EU contribution (€)

Based on estimated EU contribution value.

Search by CORDIS call code (free text) or by call identifier. This is different from live Funding & Tenders opportunities.

Matches project topic and keyword text, separate from EuroSciVoc classification.

Organization

At least one partner based in that country (CORDIS ISO code). Organization filters are combined with AND logic.

Matches legal name, short name, or organization ID among partners.

Only the organization with coordinator role in the consortium.

At least one partner with this ETL-normalized type.

Active filters

Sector: Health & BiotechCountry: FR

Results

Showing 25 of 5,505 matching projects.

ProjectEU contributionTotal cost
Efficient bio-production of next generation dyes for sustainable fashion

Horizon EuropeHorizon EuropeClosed2022FRFR

NextGen Dyes · 190199874

€1,947,888
Total €2,782,698
€2,782,698Details
TowArd demoCRatization Of ev-BAsed Therapies

Horizon EuropeHorizon EuropeClosed2022FRFR

ACROBAT · 190194936

€1,700,000
Total €2,487,651
€2,487,651Details
To deliver the first medical treatment dedicated to patients with haemorrhagic stroke

Horizon EuropeHorizon EuropeSigned2022FRFR

OP2DRAIN · 190188714

€2,500,000
Total €10,535,727
€10,535,727Details
Revolutionising allergies diagnostics with the next generation of ultra-sensitive highly multiplexed diagnostic tests based on micro-pearls

Horizon EuropeHorizon EuropeSigned2023FRFR

Nexdiag · 190186747

€2,500,000
Total €3,628,125
€3,628,125Details
Sonio: Deep-Learning for Detection and Diagnostic of Prenatal Malformations

Horizon EuropeHorizon EuropeClosed2023FRFR

d3pm · 190186381

€2,500,000
Total €5,717,543
€5,717,543Details
The World’s Only Bioprosthetic Auto-regulated Artificial Heart: From Total Artificial Heart (TAH) to Physiologic Heart Replacement Therapy (PHRT)

Horizon EuropeHorizon EuropeSigned2022FRFR

Aeson® · 190185733

€2,500,000
Total €11,560,169
€11,560,169Details
Multi-omic data driven drug discovery and indication prioritisation platform in oncology

Horizon EuropeHorizon EuropeClosed2022FRFR

mCUBE · 190185351

€2,495,789
Total €3,565,413
€3,565,413Details
Innovative multifunctional and smart coatings to prevent medical device related infections

Horizon EuropeHorizon EuropeSigned2022FRFR

SPARTHACUS · 190184905

€2,389,625
Total €3,413,751
€3,413,751Details
Innovative single-cell RNA-seq kit to support large democratization of insgle-cell analysis

Horizon EuropeHorizon EuropeTerminated2023FRFR

DEEP-IN-CELL · 190178154

€2,417,259
Total €3,453,228
€3,453,228Details
Breast self-reconstruction: The Promise of Breast Reconstruction with patients’ own tissue

Horizon EuropeHorizon EuropeSigned2022FRFR

MATTISSE · 190174063

€2,438,488
Total €3,483,555
€3,483,555Details
Saving Cardiac Arrest Patients with Hypothermic Lung Conservative Liquid Ventilation

Horizon EuropeHorizon EuropeSigned2023FRFR

Luncolive · 190172852

€2,449,869
Total €3,620,834
€3,620,834Details
Development and validation of the first digital, clinical grade flow cytometry platform for enhanced diagnosis accuracy and sustainability in immunology and hemato oncology

Horizon EuropeHorizon EuropeClosed2023FRFR

METAflow · 190166506

€2,499,579
Total €3,570,828
€3,570,828Details
Lassie: The first-ever painless breath analyser for people with diabetes, a breakthrough in blood glucose monitoring

Horizon EuropeHorizon EuropeSigned2022FRFR

Lassie · 190162033

€2,500,000
Total €8,710,500
€8,710,500Details
A novel combination treatment effective against all multidrug-resistant pathogens deemed as a critical priority by the WHO

Horizon EuropeHorizon EuropeSigned2023FRFR

sbli-ant3310 · 190159682

€2,500,000
Total €5,618,870
€5,618,870Details
Unlocking the Power of Medical Images for Surgeons

Horizon EuropeHorizon EuropeSigned2023FRFR

AVATAR · 190147557

€2,492,262
Total €3,560,375
€3,560,375Details
Saving patients from severe heart failure

Horizon EuropeHorizon EuropeSigned2022FRFR

FLOWMAKER · 190146685

€2,500,000
Total €9,903,924
€9,903,924Details
Valorisation of food production side-streams as multifunctional ingredients by an innovative fermentation process.

Horizon EuropeHorizon EuropeSigned2022FRFR

Fl'Our Planet · 190144130

€2,474,938
Total €3,535,625
€3,535,625Details
Next generation HPC/QC in silico drug discovery platform for de novo design

Horizon EuropeHorizon EuropeClosed2022FRFR

ATLAS · 190141418

€2,500,000
Total €4,249,375
€4,249,375Details
Scalable and Eco-friendly Bioproduction

Horizon EuropeHorizon EuropeSigned2023FRFR

SEB · 190139157

€1,153,390
Total €1,647,700
€1,647,700Details
LCTB-21: A DYRK1A protein kinase inhibitor for treatment of cognitive decline in Down Syndrome.

Horizon EuropeHorizon EuropeSigned2022FRFR

DOWN-AUTONOMY · 190138295

€2,500,000
Total €11,359,709
€11,359,709Details
Beta-cell recovery to counter diabetes

Horizon EuropeHorizon EuropeSigned2023FRFR

DiogenX · 190133766

€2,500,000
Total €5,673,000
€5,673,000Details
A novel and accurate emotion recognition system for real-time and continuous patient monitoring in psychiatry

Horizon EuropeHorizon EuropeSigned2023FRFR

ADAPTE · 190129251

€2,497,708
Total €3,568,155
€3,568,155Details
An innovative and versatile Additive Manufacturing Process: Dynamic Molding

Horizon EuropeHorizon EuropeSigned2023FRFR

Dynamic Molding (DM) · 190125207

€2,500,000
Total €4,159,028
€4,159,028Details
Pannexin 1 – a novel target for pediatric orphan epilepsy

Horizon EuropeHorizon EuropeSigned2023FRFR

PANNEXIN · 190121670

€2,499,500
Total €4,078,906
€4,078,906Details
SWAN: Blitzscaling the early detection of skin cancer

Horizon EuropeHorizon EuropeClosed2022FRFR

SWAN · 190119289

€2,500,000
Total €3,920,366
€3,920,366Details